Medicare Enrolled

Dr. Atam Singh, M.D.

Endocrinology · Riverside, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
5256 MISSION BLVD, Riverside, CA 92509
9519555380
In practice since 2006 (19 years)
NPI: 1548271166 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Singh from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Singh? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Singh

Dr. Atam Singh is an endocrinology specialist in Riverside, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Singh performed 3,015 Medicare services across 1,390 unique beneficiaries.

Between the years covered by Open Payments, Dr. Singh received a total of $8,379 from 47 pharmaceutical and/or device companies across 431 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Singh is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 23% volume in CA $8,379 industry payments

Medicare Practice Summary

Medicare Utilization ↗
3,015
Medicare services
Top 23% in CA for endocrinology
1,390
Unique beneficiaries
$89
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~159 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
1,733 $90 $225
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
479 $129 $304
Continuous glucose monitoring with interpretation
This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results.
388 $26 $75
Telephone medical discussion, 21-30 minutes
A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone.
295 $94 $203
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
120 $114 $342
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$8,379
Total received (2018-2024)
Avg $1,197/year across 7 years
Top 22% in CA for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
47
Companies
431
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,379 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,107
2023
$1,314
2022
$1,033
2021
$921
2020
$1,774
2019
$1,489
2018
$740

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novo Nordisk Inc
$311
Ascensia Diabetes Care Us Inc.
$119
Lilly USA, LLC
$98
Amgen Inc.
$82
ABBVIE INC.
$82
Ultragenyx Pharmaceutical Inc.
$74
Medtronic, Inc.
$66
Mannkind Corporation
$58
CeQur Corporation
$28
Ascendis Pharma Inc
$24
Averitas Pharma Inc.
$24
Abbott Laboratories
$23
AstraZeneca Pharmaceuticals LP
$21
Boehringer Ingelheim Pharmaceuticals, Inc.
$21
Antares Pharma, Inc.
$21
IBSA Pharma Inc.
$21
Xeris Pharmaceuticals, Inc.
$20
Currax Pharmaceuticals LLC
$16
Top 3 companies account for 47.6% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$1,094
Novo Nordisk Inc
$977
Lilly USA, LLC
$847
SANOFI-AVENTIS U.S. LLC
$585
Boehringer Ingelheim Pharmaceuticals, Inc.
$429
Dexcom, Inc.
$417
Abbott Laboratories
$372
Amgen Inc.
$366
Medtronic, Inc.
$344
Merck Sharp & Dohme Corporation
$333
Corcept Therapeutics
$203
Shire North American Group Inc
$177
Ascensia Diabetes Care Us Inc.
$170
AbbVie Inc.
$168
Amarin Pharma Inc.
$135
Mannkind Corporation
$126
Medtronic MiniMed, Inc.
$124
ABBVIE INC.
$123
Ultragenyx Pharmaceutical Inc.
$112
Horizon Therapeutics plc
$107
Radius Health, Inc.
$98
CeQur Corporation
$85
MannKind Corporation
$83
Amryt Pharma Holdings Ltd
$78
AbbVie, Inc.
$72
IBSA Pharma Inc.
$70
Insulet Corporation
$64
Ascendis Pharma Inc
$55
Senseonics, Incorporated
$55
Supernus Pharmaceuticals, Inc.
$45
Antares Pharma, Inc.
$44
Kyowa Kirin, Inc.
$40
Xeris Pharmaceuticals, Inc.
$35
Currax Pharmaceuticals LLC
$33
Novartis Pharmaceuticals Corporation
$29
Alexion Pharmaceuticals, Inc.
$27
Regeneron Healthcare Solutions, Inc.
$27
DEXCOM, INC.
$27
Bayer HealthCare Pharmaceuticals Inc.
$26
Averitas Pharma Inc.
$24
Ascensia Diabetes Care US Inc.
$23
PFIZER INC.
$22
RECORDATI_RARE_DISEASES_INC.
$22
Merck Sharp & Dohme LLC
$22
Esperion Therapeutics, Inc.
$22
IDORSIA PHARMACEUTICALS US INC
$21
Bayer Healthcare Pharmaceuticals Inc.
$19
Top 3 companies account for 34.8% of all-time payments
Associated products mentioned in payments ›
AFREZZA · BAQSIMI · CONTRAVE · CeQur Simplicity · Crysvita · DEXCOM CGM · DEXCOM G6 CGM SYSTEM · DEXCOM G6 TRANSMITTER · Dexcom G6 Transmitter · EVENITY · EVERSENSE 365 SENSOR KIT (RETAIL) · EVERSENSE E3 SENSOR KIT - RETAIL · Eversense · FARXIGA · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre 2 · FreeStyle Libre blood glucose Flash Monitoring System · GVOKE HYPOPEN · GVOKE PFS · Guardian Connect · HUMULIN · INTELLIS ADAPTIVESTIM · InPen · JANUVIA · JARDIANCE · Kerendia · Korlym · LEQVIO · LYUMJEV · MINIMED 770G · MINIMED 780G · MOUNJARO · MYCAPSSA · Minimed 630G · Minimed 670G System · Minimed 770G System · NATPARA · NATPARA (PARATHYROID HORMONE) · NEXLETOL · NOCDURNA · Omnipod · Ozempic · PRALUENT · PRALUENT ALIROCUMAB INJECTION · QUTENZA · QUVIVIQ · RAYOS · RYBELSUS · Repatha · Rybelsus · SOLIQUA · SOLIQUA 100/33 · SOMAVERT · STEGLUJAN · SYNTHROID · Strensiq · Synthroid · TEPEZZA · TOUJEO · TRADJENTA · TRULICITY · Tirosint · Tymlos · UBRELVY · Vascepa · Wegovy · XYOSTED
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an endocrinology specialist in Riverside?
Compare endocrinologists in the Riverside area by procedure volume, costs, and industry payment transparency.
Browse endocrinologists nearby

Geographic Context

Endocrinologists within 10 mi
50
Per 100K population
2.0
County median income
$89,672
Nearest hospital
RIVERSIDE COMMUNITY HOSPITAL
3.9 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Singh is a clinical cardiology specialist, with above-average Medicare volume (top 23% in CA), with low-engagement industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Singh experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Singh performed 1,733 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Singh receive payments from pharmaceutical companies?
Yes. Dr. Singh received a total of $8,379 from 47 companies across 431 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Singh's costs compare to other endocrinologists in Riverside?
Dr. Singh's average Medicare payment per service is $89. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Singh) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →